Douglas P.  Baker net worth and biography

Douglas Baker Biography and Net Worth

CFO of OptimizeRx

Doug joined OptimizeRx as CFO in May 2014. He spent the previous 18 years as CFO of Applied Nanotech Holdings, Inc., a public company specializing in nanotechnology research and development.

Hands-on CFO with excellent strategic vision and strong technical and problem-solving skills.

Specialties/Strengths: SEC Reporting, Registration Statements, Investor Relations, Forecasting and Budgeting, Strategic Planning and Business Planning, Fundraising Structures, Mergers and Acquisitions, Restructuring/Turnarounds, Sarbanes Oxley Compliance, Start-ups, Taxation, Litigation Support, Board of Directors.

What is Douglas P. Baker's net worth?

The estimated net worth of Douglas P. Baker is at least $544,271.40 as of September 14th, 2021. Mr. Baker owns 44,796 shares of OptimizeRx stock worth more than $544,271 as of March 28th. This net worth approximation does not reflect any other assets that Mr. Baker may own. Learn More about Douglas P. Baker's net worth.

How do I contact Douglas P. Baker?

The corporate mailing address for Mr. Baker and other OptimizeRx executives is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. OptimizeRx can also be reached via phone at (248) 651-6568 and via email at [email protected]. Learn More on Douglas P. Baker's contact information.

Has Douglas P. Baker been buying or selling shares of OptimizeRx?

Douglas P. Baker has not been actively trading shares of OptimizeRx during the last quarter. Most recently, Douglas P. Baker sold 14,000 shares of the business's stock in a transaction on Tuesday, October 5th. The shares were sold at an average price of $82.88, for a transaction totalling $1,160,320.00. Learn More on Douglas P. Baker's trading history.

Who are OptimizeRx's active insiders?

OptimizeRx's insider roster includes Douglas Baker (CFO), William Febbo (CEO), Miriam Paramore (Insider), Stephen Silvestro (Insider), and Patrick Spangler (Director). Learn More on OptimizeRx's active insiders.

Are insiders buying or selling shares of OptimizeRx?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 4,000 shares worth more than $60,760.00. The most recent insider tranaction occured on January, 9th when General Counsel Marion Odence-Ford sold 4,000 shares worth more than $60,760.00. Insiders at OptimizeRx own 4.4% of the company. Learn More about insider trades at OptimizeRx.

Information on this page was last updated on 1/9/2024.

Douglas P. Baker Insider Trading History at OptimizeRx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/5/2021Sell14,000$82.88$1,160,320.00View SEC Filing Icon  
9/28/2021Sell2,000$74.66$149,320.00View SEC Filing Icon  
9/21/2021Sell4,000$70.59$282,360.00View SEC Filing Icon  
9/14/2021Sell3,768$65.57$247,067.7644,796View SEC Filing Icon  
9/8/2021Sell10,000$67.25$672,500.0048,564View SEC Filing Icon  
8/31/2021Sell4,000$66.62$266,480.0050,796View SEC Filing Icon  
8/24/2021Sell4,000$61.50$246,000.0058,796View SEC Filing Icon  
8/20/2021Sell5,000$58.45$292,250.00View SEC Filing Icon  
7/27/2021Sell3,000$52.58$157,740.0076,796View SEC Filing Icon  
7/20/2021Sell3,000$50.90$152,700.00View SEC Filing Icon  
7/8/2021Sell13,435$56.05$753,031.7569,361View SEC Filing Icon  
6/28/2021Sell3,421$63.00$215,523.0082,796View SEC Filing Icon  
6/24/2021Sell4,000$60.00$240,000.0086,217View SEC Filing Icon  
6/7/2021Sell14,500$52.62$762,990.0075,717View SEC Filing Icon  
5/18/2021Sell14,500$45.85$664,825.0075,717View SEC Filing Icon  
1/29/2021Sell5,032$47.25$237,762.0085,902View SEC Filing Icon  
1/13/2021Sell5,000$38.89$194,450.0085,937View SEC Filing Icon  
11/11/2020Sell15,000$24.05$360,750.0075,705View SEC Filing Icon  
9/2/2020Sell10,000$20.00$200,000.0080,705View SEC Filing Icon  
8/13/2020Sell10,000$18.00$180,000.00100,671View SEC Filing Icon  
8/6/2020Sell10,000$17.01$170,100.00100,671View SEC Filing Icon  
7/16/2020Sell6,667$15.00$100,005.0082,671View SEC Filing Icon  
8/10/2018Sell4,784$12.01$57,455.84View SEC Filing Icon  
5/11/2017Buy10,000$0.77$7,700.0050,000View SEC Filing Icon  
11/14/2016Buy10,000$0.85$8,500.0040,000View SEC Filing Icon  
6/7/2016Buy10,000$1.05$10,500.0030,000View SEC Filing Icon  
11/17/2014Buy10,000$0.88$8,800.00View SEC Filing Icon  
6/5/2014Buy10,000$1.50$15,000.00View SEC Filing Icon  
See Full Table

Douglas P. Baker Buying and Selling Activity at OptimizeRx

This chart shows Douglas P Baker's buying and selling at OptimizeRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

OptimizeRx Company Overview

OptimizeRx logo
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.
Read More

Today's Range

Now: $12.15
Low: $11.65
High: $12.40

50 Day Range

MA: $14.56
Low: $11.47
High: $16.17

2 Week Range

Now: $12.15
Low: $6.92
High: $16.65

Volume

419,135 shs

Average Volume

121,884 shs

Market Capitalization

$220.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01